搜索临床试验以:200mg 依佐加滨/瑞替加滨
总计2004个结果
-
Guangdong Zhongsheng Pharmaceutical Co., Ltd.完全的
-
London School of Hygiene and Tropical MedicineNational Institute for Health Research, United Kingdom完全的
-
AstraZeneca完全的
-
Acura Pharmaceuticals Inc.King Pharmaceuticals is now a wholly owned subsidiary of Pfizer完全的
-
National Cancer Institute (NCI)完全的复发性神经母细胞瘤 | 复发性骨肉瘤 | 复发性儿童横纹肌肉瘤 | 复发性成人软组织肉瘤 | 复发性肾母细胞瘤和其他儿童肾脏肿瘤 | 以前治疗过的儿童横纹肌肉瘤 | 复发性儿童软组织肉瘤 | 复发性尤文肉瘤/外周原始神经外胚层肿瘤 | 成人横纹肌肉瘤 | 成人滑膜肉瘤 | 肺泡型儿童横纹肌肉瘤 | 胚胎性儿童横纹肌肉瘤 | 儿童滑膜肉瘤美国
-
Seoul National University Hospital完全的Simvastatin Pharmacokinetics and Gut Microbiome大韩民国
-
Lawson Health Research InstituteCanadian Institutes of Health Research (CIHR)招聘中
-
Vanderbilt University Medical CenterAminu Kano Teaching Hospital; Murtala Muhammad Specialist Hospital完全的
-
Pacira Pharmaceuticals, IncRichmond Pharmacology Limited完全的
-
Seoul National University HospitalMerck Sharp & Dohme LLC未知
-
Peter A Campochiaro, MDGenentech, Inc.完全的
-
Chattogram General HospitalFirst Affiliated Hospital Xi'an Jiaotong University; M Abdur Rahim Medical College and Hospital完全的
-
Pusan National University HospitalYonsei University完全的
-
Yonsei UniversityPusan National University Hospital完全的
-
University of Kansas Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)主动,不招人
-
Daniel Podzamczer完全的
-
Yonsei UniversityBristol-Myers Squibb; Pusan National University Hospital; Korea University Anam Hospital; Korea... 和其他合作者未知